Secondaries announced 3.24.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating Company: Novavax, Inc. Symbol: NVAX Price: Last trade $9.26 Trade Date: 3/26 Shares: 18.9 million Underwriter(s) J.P. Morgan, Citigroup Rating=Subscription Needed Company:[…]